We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · August 28, 2020

Real-World Long-Term Effectiveness of Ustekinumab in Crohn's Disease

Alimentary Pharmacology & Therapeutics


Additional Info

Disclosure statements are available on the authors' profiles:

Alimentary Pharmacology & Therapeutics
Real-World Long-Term Effectiveness of Ustekinumab in Crohn's Disease: Results From the ENEIDA Registry
Aliment. Pharmacol. Ther. 2020 Aug 08;[EPub Ahead of Print], M Iborra, B Beltrán, A Fernández-Clotet, E Iglesias-Flores, P Navarro, M Rivero, A Gutiérrez, M Sierra-Ausin, F Mesonero, R Ferreiro-Iglesias, J Hinojosa, X Calvet, B Sicilia, C González-Muñoza, B Antolín, M González-Vivo, AY Carbajo, S García-López, A Martín-Cardona, G Surís, MD Martin-Arranz, R de Francisco, F Cañete, E Domènech, P Nos

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading